Brief: Anika Therapeutics Names Dr. Cheryl Blanchard As Interim CEO
12/02/2020 21:38
Feb 12 (Reuters) - Anika Therapeutics Inc ANIK.O :
* ANIKA THERAPEUTICS NAMES BOARD MEMBER DR. CHERYL BLANCHARD
AS
INTERIM CEO
* ANIKA THERAPEUTICS INC - BOARD CONTINUES ITS SEARCH TO
IDENTIFY
A NEW CEO FOLLOWING RECENT PASSING OF JOSEPH DARLING
* ANIKA THERAPEUTICS INC - IN CONNECTION WITH BLANCHARD'S
APPOINTMENT, PREVIOUSLY ANNOUNCED INTERIM OFFICE OF PRESIDENT
HAS BEEN DISSOLVED
Source text for Eikon: ID:nGNXbbrcr6
Further company coverage: ANIK.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Anika Therapeutics
See all newsAnika Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Anika Therapeutics Q2 revenue rises, lifts 2026 outlook
Anika Therapeutics Inc expected to post a loss of 8 cents a share - Earnings Preview
Brief: Anika Therapeutics Enters Fifth Amendment To Credit Agreement - SEC Filing
Anika Therapeutics Q1 revenue rises 13%